QLQuentin Leyrolle

Quentin Leyrolle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Quentin Leyrolle has a total of 93 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Translational evidence of tricarboxylic acid cycle disruptions in obesity: relevance to neuropsychiatric symptoms

    by Cassandra E. Gheorghe, Juliette Montet, Sylvie Vancassel, Camille Amadieu, Quentin Leyrolle, Sandra Dexpert, Cédric Beau, Damien Forestier, Patrick Ledaguenel, Eric Magne, et al.

    Obesity is a major public health concern frequently associated with an increased susceptibility to neuropsychiatric symptoms, highlighting the need to elucidate the pathophysiological mechanisms underlying this comorbidity. While converging evidence supports a role for chronic low-grade inflammation, emerging data suggest that additional immunometabolic alterations may also participate, particularly disruptions in mitochondrial tricarboxylic acid (TCA) cycle activity, a central component of cellular energy production. This translational study investigated whether TCA cycle alterations are associated with obesity-related neuropsychiatric symptoms, and whether their associations differ across symptom dimensions. Plasma levels of TCA cycle metabolites were assessed in 83 adults with obesity (BMI > 30 kg/m²), along with depressive (Montgomery-Asberg Depression Rating Scale, MADRS), anxiety (State-Trait Anxiety Inventory, STAI-state form), and fatigue symptoms (Multidimensional Fatigue Inventory, MFI). Concurrently, depressive-like (Sucrose Preference Test, Forced Swim Test) and anxiety-like behaviors (Elevated Plus-Maze) were measured in C57BL/6J male mice chronically exposed to high-fat diet (HFD), together with plasma and brain (striatum, hippocampus, frontal cortex) TCA cycle metabolite levels. Lower circulating metabolite levels were associated with more severe neuropsychiatric symptoms in obese participants, particularly fatigue and reduced motivation. In addition, the preclinical study identified region-specific associations between brain TCA cycle metabolite levels and behavioral outcomes, which may be modulated by HFD exposure. By providing novel evidence linking TCA cycle dysregulation and neuropsychiatric comorbidities in obesity, these findings highlight metabolites of potential interest and suggest that mitochondrial immunometabolic alterations may contribute to obesity-related neuropsychiatric symptoms.

  • Rôle des acides gras polyinsaturés n-3 dans le développement cérébral normal et pathologique

    by Quentin Leyrolle

    Les apports nutritionnels périnataux en acide gras polyinsaturés n-3 et n-6 (AGPI n-3 et n-6), communément appelés oméga-3 et oméga-6, sont essentiels pour le développement cérébral. Ces lipides ne peuvent être synthétisés par notre organisme et doivent donc être apportés par l’alimentation selon un ratio d’un AGPI n-3 pour quatre AGPI n-6. L’alimentation occidentale a drastiquement évolué au cours des 70 dernières années, vers une consommation excessive d’oméga-6 et une diminution des apports en oméga-3. Ceci est corrélé à un accroissement du nombre d’enfants atteints de pathologies neurodéveloppementales. Cependant, le lien entre nutrition périnatale et neurodéveloppement reste peu compris. L’objectif principal de ma thèse a été d’étudier les mécanismes cellulaires et moléculaires par lesquels la réduction des apports périnataux en oméga-3 altèrent la mise en place des réseaux neuronaux, en me focalisant sur les interactions entre cellules gliales, microglie et oligodendrocytes, et neurones. Nos travaux montrent que la carence périnatale en AGPI n-3 entraîne 1) une altération des fonctions microgliales et oligodendrocytaires au cours du développement cérébral; 2) une augmentation de l'élagage des épines dendritiques par la microglie et des déficits dans le processus de myélinisation; 3) l'établissement de réseaux neuronaux dysfonctionnels dans l'hippocampe et le cortex préfrontal; 4) des déficits d'apprentissage, de sociabilité et l'apparition de comportements anxieux. Par ailleurs, nous avons montré que la carence en AGPI n-3, pendant la période périnatale, aggrave les effets délétères de l'inflammation prénatale. Les faibles apports en AGPI n-3 entrainent 1) une exacerbation de la réaction inflammatoire au challenge prénatal; 2) des altérations plus marquées et plus durables du renouvellement synaptique dans l'hippocampe; 3) des changements de la réactivité inflammatoire des lymphocytes intestinaux persistant à l'âge adulte 4) des déficits de mémoire et de l'hyperactivité chez la descendance à l'âge adulte. Dans l'ensemble, le présent travail a précisé certains des mécanismes par lesquels la carence en AGPI n-3 affecte le cerveau en développement en soulignant son effet néfaste sur la fonction microgliale et oligodendrocytes ainsi qu'en montrant comment elle sensibilise le cerveau en développement à d'autres événements négatifs.

  • Open Access

    Blood metabolomic profiling reveals new targets in the management of psychological symptoms associated with severe alcohol use disorder

    by Sophie Leclercq, Hany Ahmed, Camille Amadieu, Géraldine Petit, Ville Koistinen, Quentin Leyrolle, Marie Poncin, Peter Stärkel, Eloise Kok, Pekka J Karhunen, et al.

    Background: Alcohol use disorder (AUD) is a global health problem with limited therapeutic options. The biochemical mechanisms that lead to this disorder are not yet fully understood, and in this respect, metabolomics represents a promising approach to decipher metabolic events related to AUD. The plasma metabolome contains a plethora of bioactive molecules that reflects the functional changes in host metabolism but also the impact of the gut microbiome and nutritional habits.Methods: In this study, we investigated the impact of severe AUD (sAUD), and of a 3-week period of alcohol abstinence, on the blood metabolome (non-targeted LC-MS metabolomics analysis) in 96 sAUD patients hospitalized for alcohol withdrawal.Results: We found that the plasma levels of different lipids ((lyso)phosphatidylcholines, long-chain fatty acids), short-chain fatty acids (i.e. 3-hydroxyvaleric acid) and bile acids were altered in sAUD patients. In addition, several microbial metabolites, including indole-3-propionic acid, p-cresol sulfate, hippuric acid, pyrocatechol sulfate, and metabolites belonging to xanthine class (paraxanthine, theobromine and theophylline) were sensitive to alcohol exposure and alcohol withdrawal. 3-Hydroxyvaleric acid, caffeine metabolites (theobromine, paraxanthine, and theophylline) and microbial metabolites (hippuric acid and pyrocatechol sulfate) were correlated with anxiety, depression and alcohol craving. Metabolomics analysis in postmortem samples of frontal cortex and cerebrospinal fluid of those consuming a high level of alcohol revealed that those metabolites can be found also in brain tissue.Conclusions: Our data allow the identification of neuroactive metabolites, from interactions between food components and microbiota, which may represent new targets arising in the management of neuropsychiatric diseases such as sAUD.Funding: Gut2Behave project was initiated from ERA-NET NEURON network (Joint Transnational Call 2019) and was financed by Academy of Finland, French National Research Agency (ANR-19-NEUR-0003-03) and the Fonds de la Recherche Scientifique (FRS-FNRS; PINT-MULTI R.8013.19, Belgium). Metabolomics analysis of the TSDS samples was supported by grant from the Finnish Foundation for Alcohol Studies.


  • Open Access

    Dietary Marine Hydrolysate Improves Memory Performance and Social Behavior through Gut Microbiota Remodeling during Aging

    by Camille Mougin, Mathilde Chataigner, Céline Lucas, Quentin Leyrolle, Véronique Pallet, Sophie Layé, Elodie Bouvret, Anne-Laure Dinel, Corinne Joffre

    Aging is characterized by a decline in social behavior and cognitive functions leading to a decrease in life quality. In a previous study, we show that a fish hydrolysate supplementation prevents age-related decline in spatial short-term memory and long-term memory and anxiety-like behavior and improves the stress response in aged mice. The aim of this study was to determine the effects of a fish hydrolysate enriched with EPA/DHA or not on the cognitive ability and social interaction during aging and the biological mechanisms involved. We showed for the first time that a fish hydrolysate enriched with EPA/DHA or not improved memory performance and preference for social novelty that were diminished by aging. These changes were associated with the modulation of the gut microbiota, normalization of corticosterone, and modulation of the expression of genes involved in the mitochondrial respiratory chain, circadian clock, neuroprotection, and antioxidant activity. Thus, these changes may contribute to the observed improvements in social behavior and memory and reinforced the innovative character of fish hydrolysate in the prevention of age-related impairments.


  • Open Access

    The gut-derived metabolites as mediators of the effect of healthy nutrition on the brain

    by Quentin Leyrolle, Lucia Prado-Perez, Sophie Layé

    Nutrition is now well recognized to be an environmental factor which positively or negatively influences the risk to develop neurological and psychiatric disorders. The gut microbiota has recently been shown to be an important actor mediating the relationship between environmental factors, including nutrition, and brain function. While its composition has been widely studied and associated with the risk of brain diseases, the mechanisms underlying the relationship between the gut and brain diseases remain to be explored. The wide range of bioactive molecules produced by the gut microbiota, called gut-derived metabolites (GDM), represent new players in the gut to brain interactions and become interesting target to promote brain health. The aim of this narrative review is to highlight some GDMs of interest that are produced in response to healthy food consumption and to summarize what is known about their potential effects on brain function. Overall, GDMs represent future useful biomarkers for the development of personalized nutrition. Indeed, their quantification after nutritional interventions is a useful tool to determine individuals’ ability to produce microbiota-derived bioactive compounds upon consumption of specific food or nutrients. Moreover, GDMs represent also a new therapeutic approach to counteract the lack of response to conventional nutritional interventions.


  • Open Access

    Link between gut microbiota and health outcomes in inulin -treated obese patients: Lessons from the Food4Gut multicenter randomized placebo-controlled trial

    by Sophie Hiel, Marco A. Gianfrancesco, Julie Rodriguez, Daphnée Portheault, Quentin Leyrolle, Laure B. Bindels, Carolina Gomes da Silveira Cauduro, Maria D.G.H. Mulders, Giorgia Zamariola, Anne-Sophie Azzi, et al.


  • Open Access

    Dietary omega-3 deficiency exacerbates inflammation and reveals spatial memory deficits in mice exposed to lipopolysaccharide during gestation

    by V.F. Labrousse, Q. Leyrolle, C. Amadieu, A. Aubert, A Sere, E. Coutureau, S. Grégoire, L. Bretillon, V. Pallet, P. Gressens, et al.


  • Open Access

    Neuroinflammation in Autism: Plausible Role of Maternal Inflammation, Dietary Omega 3, and Microbiota

    by Charlotte Madore, Quentin Leyrolle, Chloé Lacabanne, Anouk Benmamar-Badel, Corinne Joffre, Agnes Nadjar, Sophie Layé

    Several genetic causes of autism spectrum disorder (ASD) have been identified. However, more recent work has highlighted that certain environmental exposures early in life may also account for some cases of autism. Environmental insults during pregnancy, such as infection or malnutrition, seem to dramatically impact brain development. Maternal viral or bacterial infections have been characterized as disruptors of brain shaping, even if their underlying mechanisms are not yet fully understood. Poor nutritional diversity, as well as nutrient deficiency, is strongly associated with neurodevelopmental disorders in children. For instance, imbalanced levels of essential fatty acids, and especially polyunsaturated fatty acids (PUFAs), are observed in patients with ASD and other neurodevelopmental disorders (e.g., attention deficit hyperactivity disorder (ADHD) and schizophrenia). Interestingly, PUFAs, and specifically n-3 PUFAs, are powerful immunomodulators that exert anti-inflammatory properties. These prenatal dietary and immunologic factors not only impact the fetal brain, but also affect the microbiota. Recent work suggests that the microbiota could be the missing link between environmental insults in prenatal life and future neurodevelopmental disorders. As both nutrition and inflammation can massively affect the microbiota, we discuss here how understanding the crosstalk between these three actors could provide a promising framework to better elucidate ASD etiology.


  • Open Access

    Correction: Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling

    by Oihane Abiega, Sol Beccari, Irune Diaz-Aparicio, Agnes Nadjar, Sophie Layé, Quentin Leyrolle, Diego Gómez-Nicola, María Domercq, Alberto Pérez-Samartín, Víctor Sánchez-Zafra, et al.

    [This corrects the article DOI: 10.1371/journal.pbio.1002466.].